FDA 483 - Tanvex BioPharma USA, Inc - January 24, 2023
FDA 483 for Tanvex BioPharma USA, Inc on January 24, 2023. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for Tanvex BioPharma USA, Inc on January 24, 2023. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Tanvex BioPharma USA, IncInspection Date
January 24, 2023
Product Type
biologics
ID: a9d30f1e-d696-45b8-b908-bd03a01a3ccb
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox